• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Daxor Corporation - Closed End Fund (NQ: DXR )

8.350 +0.210 (+2.58%)
Streaming Delayed Price Updated: 3:08 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,086
Open 8.040
Bid (Size) 8.170 (2)
Ask (Size) 8.430 (4)
Prev. Close 8.140
Today's Range 8.040 - 8.350
52wk Range 7.190 - 10.04
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 22, 2023
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga
Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
May 22, 2023
Gainers SeqLL Inc. (NASDAQ: SQL) shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss. 
Via Benzinga

Performance

YTD
-12.11%
-12.11%
1 Month
-10.06%
-10.06%
3 Month
-11.64%
-11.64%
6 Month
-10.79%
-10.79%
1 Year
-1.65%
-1.65%

More News

Read More
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
November 17, 2022
From Daxor Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 15, 2022
Via Benzinga
Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected
November 15, 2022
Via Benzinga
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
November 15, 2022
From Daxor Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 15, 2022
Via Benzinga
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
November 14, 2022
From Daxor Corporation
Via GlobeNewswire
Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes and Reduce Costs
November 10, 2022
From Daxor Corporation
Via GlobeNewswire
Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure
November 03, 2022
From Daxor Corporation
Via GlobeNewswire
Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2022
October 31, 2022
From Daxor Corporation
Via GlobeNewswire
Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting
October 05, 2022
From Daxor Corporation
Via GlobeNewswire
DAXOR CORPORATION TO EXHIBIT AND PRESENT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE FALL’22 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100®)
October 04, 2022
From Daxor Corporation
Via GlobeNewswire
Study Data from Mayo Clinic on Heart Failure Treatment Effectiveness Utilizing Daxor BVA-100 Presented at Key Scientific Meeting
October 04, 2022
From Daxor Corporation
Via GlobeNewswire
New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100® Lowers Hospital Length of Stay by 55%
October 03, 2022
From Daxor Corporation
Via GlobeNewswire
New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
October 03, 2022
From Daxor Corporation
Via GlobeNewswire
New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures
October 03, 2022
From Daxor Corporation
Via GlobeNewswire
Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Over-Year and Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
July 27, 2022
From Daxor Corporation
Via GlobeNewswire
32 Stocks Moving in Friday's Pre-Market Session
July 23, 2021
Via Benzinga
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
May 27, 2021
From MicroCap Rodeo
Via AccessWire
64 Biggest Movers From Friday
June 07, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 13, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
April 16, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 13, 2021
Via Benzinga
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap